Implications of methodological differences in digital electrocardiogram interval measurement

Journal of Electrocardiology

Volumn 39, Issue 4 SUPPL., 2006, Pages

  Badilini, Fabio ^a   Sarapa, Nenad ^b  

^a AMPS LLC   (United States)

^b DAIICHI SANKYO INC   (United States)

Author keywords

Clinical trials; QT interval

Indexed keywords

SOTALOL;

ARTICLE; DIGITAL IMAGING; DISPLAY SYSTEM; ELECTROCARDIOGRAM; ELECTRODE; HUMAN; INTERMETHOD COMPARISON; METHODOLOGY; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RR INTERVAL; VOLUNTEER;

ALGORITHMS; DIAGNOSIS, COMPUTER-ASSISTED; ELECTROCARDIOGRAPHY; HUMANS; LONG QT SYNDROME; PRACTICE GUIDELINES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIGNAL PROCESSING, COMPUTER-ASSISTED;

EID: 33749068238     PISSN: 00220736     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jelectrocard.2006.05.030     Document Type: Article

References (14)

1. Center for Drug Evaluation and Research (CDER). Digital FDA initiative. http://www.fda.gov/cder/regulatory/ersr/default.htm#ECG
2. Stockbridge N., and Throckmorton D.C. Regulatory advice on evaluation of the proarrhythmic potential of drugs. J Electrocardiol 37 Suppl (2004) 40
3. Stockbridge N., and Brown B.D. Annotated ECG waveform data at FDA. J Electrocardiol 37 Suppl (2004) 83
4. Points to consider: the assessment of the potential for QT interval prolongation by non-cardiovascular medicinal products (1997), Committee for Proprietary Medicinal Products (CPMP), London
5. Murray A., McLaughlin N.B., Bourke J.P., Doig J.C., Furniss S.S., and Campbell R.W.P. Errors in manual measurement of QT intervals. Br Heart J 71 (1994) 386
6. Morganroth J., and Silber S.S. How to obtain and analyze electrocardiograms in clinical trial. ANE 4 (1999) 425
7. Pratt C.M., Ruberg S., Morganroth J., et al. Dose-response relation between terfenadine (Seldane) and the QTc interval on the scalar electrocardiogram: distinguishing a drug effect from spontaneous variability. Am Heart J 131 (1996) 472
8. Malik M., and Bradford A. Human precision of operating a digitizing board: implications for electrocardiogram measurements. PACE 21 (1998) 1656
9. McLaughlin N.B., Campbell R.W.F., and Murray A. Comparison of automatic QT measurement techniques in the normal 12-lead electrocardiogram. Br Heart J 74 (1995) 84
10. Savelieva I., Yi G., Guo X., Hnatkova K., and Malik M. Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion. Am J Cardiol 81 (1998) 471
11. Darpo B., Agin M., Kazierad D.J., et al. Man versus machine: Is there an optimal method for QT measurement in thorough QT studies?. J Clin Pharmacol 46 (2006) 598
12. The clinical evaluation of QT/QTc interval prolongation and proarrhythmic potential for non-antiarrhythmic drugs. International Conference on Harmonization (ICH), London (2005)
13. Azie N.E., Adams G., Darpo B., et al. Comparing methods of measurement for detecting drug-induced changes in the QT interval: Implications for the thoroughly conducted ECG studies. Ann Noninvasive Electrocardiol 9 (2004) 166
14. Sarapa N., Morganroth J., Couderc J.P., et al. Electrocardiographic identification of drug-induced QT prolongation: assessment by different recording and measurement methods. Ann Noninvasive Electrocardiol 9 (2004) 48